Safety and efficacy of PRO 542 in the treatment of HIV-infected patients
Phase of Trial: Phase II
Latest Information Update: 07 Dec 2015
At a glance
- Drugs PRO 542 (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 02 Oct 2008 Actual end date (June 2005) added as reported by ClinicalTrials.gov.
- 28 Mar 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov
- 18 Oct 2005 New trial record.